|
|
|
|
|
|
|
|
|
|
Previous: CHOLESTECH CORPORATION, 10-Q, 2000-08-09 |
Next: CELLEGY PHARMACEUTICALS INC, 10-Q/A, 2000-08-09 |
<TABLE> <S> <C>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> MAR-30-2001
<PERIOD-START> APR-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 6,229
<SECURITIES> 3,833
<RECEIVABLES> 2,834
<ALLOWANCES> 234
<INVENTORY> 3,862
<CURRENT-ASSETS> 18,538
<PP&E> 16,874
<DEPRECIATION> 7,305
<TOTAL-ASSETS> 33,143
<CURRENT-LIABILITIES> 5,357
<BONDS> 0
0
0
<COMMON> 72,305
<OTHER-SE> (44,519)
<TOTAL-LIABILITY-AND-EQUITY> 33,143
<SALES> 8,888
<TOTAL-REVENUES> 8,888
<CGS> 3,417
<TOTAL-COSTS> 7,936
<OTHER-EXPENSES> 150
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> 990
<INCOME-TAX> 41
<INCOME-CONTINUING> 949
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 949
<EPS-BASIC> 0.08
<EPS-DILUTED> 0.08
</TABLE>
|
|